NextCure
NXTC
83 hedge funds and large institutions have $158M invested in NextCure in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 12 closing their positions.
87% more call options, than puts
Call options by funds: $2.59M | Put options by funds: $1.38M
67% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 12
11% more funds holding
Funds holding: 75 → 83 (+8)
1% more capital invested
Capital invested by funds: $156M → $158M (+$2.1M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.13% less ownership
Funds ownership: 5.52% → 4.4% (-1.1%)
24% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$12M |
| 2 |
LPC
Lion Point Capital
New York
|
+$3.23M |
| 3 |
BlackRock
New York
|
+$3.08M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$1.05M |
| 5 |
Goldman Sachs
New York
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$23.5M |
| 2 |
CPX
Canaan Partners X
Menlo Park,
California
|
-$9.4M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.26M |
| 4 |
Millennium Management
New York
|
-$4.38M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.65M |
NXTC Hedge Fund Activity: Q4 2020 in Review
83 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2020, worth a combined $158M — up 1.3% from $156M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new NXTC positions and 12 closed out — a net gain of 8 holders — while 22 added to existing stakes and 29 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $12M. The largest seller was Sofinnova Investments, exiting entirely with an estimated $23.5M sold.
- 83 institutional investors held NextCure (NXTC) as of Q4 2020, up from 75 in Q3 2020.
- Funds reported $158M of NextCure stock for Q4 2020, up 1.3% quarter-over-quarter.
- 20 funds opened new NextCure positions in Q4 2020 and 12 closed out, a net change of +8 holders.
- The largest NextCure buyer in Q4 2020 was Morgan Stanley, an estimated $12M added.
- The largest NextCure seller in Q4 2020 was Sofinnova Investments, an estimated $23.5M sold.
Based on aggregated 13F filings for Q4 2020.